Supplementary Table 2 from ABBV-303 Is an NK-cell Engager Specific for c-Met–Expressing Tumors

2026 Open access

Read full text
Authors: Jennifer D. Stone, Kamonwan Fish, Devika Ashok, Laura M. McKay, Saeed Salehin Akhand, Enrico L. DiGiammarino, Hector David Inzunza, Joann P. Palma, Cormac Cosgrove, Paul A. Ellis, David Peetz, Stephanie Shee
+4 more Adam S. Chervin, Claudina Stevenson, Tamar Uziel, Edward B. Reilly
DOI: 10.1158/0008-5472.31228573
Cited by: 0

Abstract

Primary diagnosis, previous treatment, and current treatment information of solid tumor patients tested in Supplementary Figure 3.

Fields of Study & Subjects

Immune Cell Function and Interaction Monoclonal and Polyclonal Antibodies Research Cancer Immunotherapy and Biomarkers

Publication details

Publication date
2 February 2026